• 2022-09-26
    Last Updated
  • 200
    Pages

Next Generation Cancer Diagnostic Market - Forecast(2022 - 2030)

DESCRIPTION
TABLE OF CONTENT

The Next Generation Cancer Diagnostic Market research report includes Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the Next Generation Cancer Diagnostic market growth.

Global Next Generation Cancer Diagnostic Market: Regional Analysis

The Next Generation Cancer Diagnostic report offers in-depth assessment of the growth and other aspects of the Next Generation Cancer Diagnostic market in important regions. Key regions covered in the report are North America, Europe, Asia-Pacific and Latin America.

The Next Generation Cancer Diagnostic report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2021 to 2030 for Next Generation Cancer Diagnostic market. These analyses will help the reader to understand the potential worth of investment in a particular region into Next Generation Cancer Diagnostic market.

Global Next Generation Cancer Diagnostic Market: Competitive Landscape

This section of the Next Generation Cancer Diagnostic report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the Next Generation Cancer Diagnostic market. The comprehensive Next Generation Cancer Diagnostic report provides a significant microscopic look at the Next Generation Cancer Diagnostic market. The reader can identify the footprints of the manufacturers by knowing about the global Next Generation Cancer Diagnostic revenue of manufacturers, during the forecast period of 2021 to 2030.

Major Key Points of Next Generation Cancer Diagnostic Market

  • Next Generation Cancer Diagnostic Market Overview
  • Next Generation Cancer Diagnostic Market Competition
  • Next Generation Cancer Diagnostic Market, Revenue and Price Trend
  • Next Generation Cancer Diagnostic Market Analysis by Application
  • Company Profiles and Key Figures in Next Generation Cancer Diagnostic Market
  • Market Dynamics for Next Generation Cancer Diagnostic market
  • Methodology and Data Source for Next Generation Cancer Diagnostic market

Companies Profiled in this Next Generation Cancer Diagnostic report includes: GE Healthcare (United States), Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Qiagen (Germany), Novartis AG (Switzerland), Abbott (United States), Thermo Fisher Scientific, Inc. (United States), Opko Health, Inc. (United States), Myriad Genetics, Inc (United States), Agilent Technologies (United States), Cepheid, PerkinElmer, Genomic Health, Inc., Illumina, Inc.

By Application
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
By Function
Therapeutic Monitoring
Companion Diagnostics
Prognostics
Cancer Screening
Risk Analysis

By Technology
Next Generation Sequencing
QPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein Microarrays
DNA Microarrays

By End User
Academic Institutes & Research Centres
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Other End Users

By Cancer
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Others

Leading market players and manufacturers are studied to help give a brief idea about them in the Next Generation Cancer Diagnostic report. The challenges faced by them and the reasons they are on that position is explained to help make a well-informed decision. Competitive landscape of Next Generation Cancer Diagnostic market is given presenting detailed insights into the company profiles, developments, merges, acquisitions, economic status and best SWOT analysis.

Chapter 1 Global Next Generation Cancer Diagnostic Market Overview

1.1 Introduction
1.2 Taxonomy
1.2.1 By Product Type & End User
1.2.2 By Region
1.3 Drivers for Next Generation Cancer Diagnostic Market
1.4 Restraints for Next Generation Cancer Diagnostic Market
1.5 Opportunities for Next Generation Cancer Diagnostic Market
1.6 Trends for Next Generation Cancer Diagnostic Market
1.7 COVID-19 Impact Assessment on Next Generation Cancer Diagnostic Industry
1.8 Macro-economic Factors
1.9 Regulatory Framework
1.10 Pricing Analysis by Region, 2020
1.11 Opportunity Map Analysis
1.12 Opportunity Orbits
1.13 Market Investment Feasibility Index
1.14 PEST Analysis
1.15 PORTERS Five Force Analysis
1.16 Go to Market Strategy
1.17 Value Chain Analysis
1.18 Cost Structure Analysis
1.19 Regional Market Share and BPS Analysis

Chapter 2 Global Next Generation Cancer Diagnostic Market Overview

2.1 Global Next Generation Cancer Diagnostic Market by Product Type
2.1.1 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
2.1.2 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
2.1.3 Global Next Generation Cancer Diagnostic Market Attractiveness Analysis by Product Type, (2013-2020)
2.2 Global Next Generation Cancer Diagnostic Market by End User
2.2.1 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
2.2.2 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
2.2.3 Global Next Generation Cancer Diagnostic Market Attractiveness Analysis by End User, (2013-2020)
2.3 Global Next Generation Cancer Diagnostic Market by Region
2.3.1 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
2.3.2 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
2.3.3 Global Next Generation Cancer Diagnostic Market Attractiveness Analysis by Region, (2013-2020)
2.4 Global Next Generation Cancer Diagnostic Market Outlook (2013-2029)
2.4.1 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) (2013-2020)
2.4.2 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) (2021-2029)
2.5 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by Regions
2.5.1 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
2.5.2 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
2.6 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by Product Type
2.6.1 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
2.6.2 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
2.7 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by End User
2.7.1 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
2.7.2 Global Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
2.8 Global Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate Comparison (2014-2029)
2.8.1 Global Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by Region
2.8.2 Global Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by Product Type
2.8.3 Global Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by End User
2.9 Global Next Generation Cancer Diagnostic Market Share Comparison (2013-2029)
2.9.1 Global Next Generation Cancer Diagnostic Market Share by Region
2.9.2 Global Next Generation Cancer Diagnostic Market Share by Product Type
2.9.3 Global Next Generation Cancer Diagnostic Market Share by End User

Chapter 3 North America Next Generation Cancer Diagnostic Market Overview

3.1 North America Next Generation Cancer Diagnostic Market by Product Type
3.1.1 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
3.1.2 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
3.1.3 North America Next Generation Cancer Diagnostic Market Attractiveness Analysis by Product Type, (2013-2020)
3.2 North America Next Generation Cancer Diagnostic Market by End User
3.2.1 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
3.2.2 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
3.2.3 North America Next Generation Cancer Diagnostic Market Attractiveness Analysis by End User, (2013-2020)
3.3 North America Next Generation Cancer Diagnostic Market by Region
3.3.1 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
3.3.2 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
3.3.3 North America Next Generation Cancer Diagnostic Market Attractiveness Analysis by Region, (2013-2020)
3.4 North America Next Generation Cancer Diagnostic Market Outlook (2013-2029)
3.4.1 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) (2013-2020)
3.4.2 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) (2021-2029)
3.5 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by Regions
3.5.1 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
3.5.2 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
3.6 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by Product Type
3.6.1 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
3.6.2 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
3.7 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by End User
3.7.1 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
3.7.2 North America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
3.8 North America Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate Comparison (2014-2029)
3.8.1 North America Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by Region
3.8.2 North America Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by Product Type
3.8.3 North America Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by End User
3.9 North America Next Generation Cancer Diagnostic Market Share Comparison (2013-2029)
3.9.1 North America Next Generation Cancer Diagnostic Market Share by Region
3.9.2 North America Next Generation Cancer Diagnostic Market Share by Product Type
3.9.3 North America Next Generation Cancer Diagnostic Market Share by End User

Chapter 4 Europe Next Generation Cancer Diagnostic Market Overview

4.1 Europe Next Generation Cancer Diagnostic Market by Product Type
4.1.1 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
4.1.2 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
4.1.3 Europe Next Generation Cancer Diagnostic Market Attractiveness Analysis by Product Type, (2013-2020)
4.2 Europe Next Generation Cancer Diagnostic Market by End User
4.2.1 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
4.2.2 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
4.2.3 Europe Next Generation Cancer Diagnostic Market Attractiveness Analysis by End User, (2013-2020)
4.3 Europe Next Generation Cancer Diagnostic Market by Region
4.3.1 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
4.3.2 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
4.3.3 Europe Next Generation Cancer Diagnostic Market Attractiveness Analysis by Region, (2013-2020)
4.4 Europe Next Generation Cancer Diagnostic Market Outlook (2013-2029)
4.4.1 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) (2013-2020)
4.4.2 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) (2021-2029)
4.5 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by Regions
4.5.1 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
4.5.2 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
4.6 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by Product Type
4.6.1 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
4.6.2 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
4.7 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by End User
4.7.1 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
4.7.2 Europe Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
4.8 Europe Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate Comparison (2014-2029)
4.8.1 Europe Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by Region
4.8.2 Europe Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by Product Type
4.8.3 Europe Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by End User
4.9 Europe Next Generation Cancer Diagnostic Market Share Comparison (2013-2029)
4.9.1 Europe Next Generation Cancer Diagnostic Market Share by Region
4.9.2 Europe Next Generation Cancer Diagnostic Market Share by Product Type
4.9.3 Europe Next Generation Cancer Diagnostic Market Share by End User

Chapter 5 Asia Pacific Next Generation Cancer Diagnostic Market Overview

5.1 Asia Pacific Next Generation Cancer Diagnostic Market by Product Type
5.1.1 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
5.1.2 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
5.1.3 Asia Pacific Next Generation Cancer Diagnostic Market Attractiveness Analysis by Product Type, (2013-2020)
5.2 Asia Pacific Next Generation Cancer Diagnostic Market by End User
5.2.1 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
5.2.2 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
5.2.3 Asia Pacific Next Generation Cancer Diagnostic Market Attractiveness Analysis by End User, (2013-2020)
5.3 Asia Pacific Next Generation Cancer Diagnostic Market by Region
5.3.1 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
5.3.2 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
5.3.3 Asia Pacific Next Generation Cancer Diagnostic Market Attractiveness Analysis by Region, (2013-2020)
5.4 Asia Pacific Next Generation Cancer Diagnostic Market Outlook (2013-2029)
5.4.1 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) (2013-2020)
5.4.2 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) (2021-2029)
5.5 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by Regions
5.5.1 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
5.5.2 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
5.6 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by Product Type
5.6.1 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
5.6.2 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
5.7 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by End User
5.7.1 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
5.7.2 Asia Pacific Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
5.8 Asia Pacific Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate Comparison (2014-2029)
5.8.1 Asia Pacific Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by Region
5.8.2 Asia Pacific Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by Product Type
5.8.3 Asia Pacific Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by End User
5.9 Asia Pacific Next Generation Cancer Diagnostic Market Share Comparison (2013-2029)
5.9.1 Asia Pacific Next Generation Cancer Diagnostic Market Share by Region
5.9.2 Asia Pacific Next Generation Cancer Diagnostic Market Share by Product Type
5.9.3 Asia Pacific Next Generation Cancer Diagnostic Market Share by End User

Chapter 6 South America Next Generation Cancer Diagnostic Market Overview

6.1 South America Next Generation Cancer Diagnostic Market by Product Type
6.1.1 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
6.1.2 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
6.1.3 South America Next Generation Cancer Diagnostic Market Attractiveness Analysis by Product Type, (2013-2020)
6.2 South America Next Generation Cancer Diagnostic Market by End User
6.2.1 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
6.2.2 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
6.2.3 South America Next Generation Cancer Diagnostic Market Attractiveness Analysis by End User, (2013-2020)
6.3 South America Next Generation Cancer Diagnostic Market by Region
6.3.1 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
6.3.2 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
6.3.3 South America Next Generation Cancer Diagnostic Market Attractiveness Analysis by Region, (2013-2020)
6.4 South America Next Generation Cancer Diagnostic Market Outlook (2013-2029)
6.4.1 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) (2013-2020)
6.4.2 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) (2021-2029)
6.5 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by Regions
6.5.1 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
6.5.2 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
6.6 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by Product Type
6.6.1 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
6.6.2 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
6.7 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by End User
6.7.1 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
6.7.2 South America Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
6.8 South America Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate Comparison (2014-2029)
6.8.1 South America Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by Region
6.8.2 South America Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by Product Type
6.8.3 South America Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by End User
6.9 South America Next Generation Cancer Diagnostic Market Share Comparison 2013-2029
6.9.1 South America Next Generation Cancer Diagnostic Market Share by Region
6.9.2 South America Next Generation Cancer Diagnostic Market Share by Product Type
6.9.3 South America Next Generation Cancer Diagnostic Market Share by End User

Chapter 7 MEA Next Generation Cancer Diagnostic Market Overview

7.1 MEA Next Generation Cancer Diagnostic Market by Product Type
7.1.1 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2029)
7.1.2 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by Product Type in 2019
7.1.3 MEA Next Generation Cancer Diagnostic Market Attractiveness Analysis by Product Type, (2013-2020)
7.2 MEA Next Generation Cancer Diagnostic Market by End User
7.2.1 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2029)
7.2.2 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by End User in 2019
7.2.3 MEA Next Generation Cancer Diagnostic Market Attractiveness Analysis by End User, (2013-2020)
7.3 MEA Next Generation Cancer Diagnostic Market by Region
7.3.1 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2029)
7.3.2 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Market Share by Region in 2019
7.3.3 MEA Next Generation Cancer Diagnostic Market Attractiveness Analysis by Region, (2013-2020)
7.4 MEA Next Generation Cancer Diagnostic Market Outlook (2013-2029)
7.4.1 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) (2013-2020)
7.4.2 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) (2021-2029)
7.5 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by Regions
7.5.1 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2013-2020)
7.5.2 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Region (2021-2029)
7.6 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by Product Type
7.6.1 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2013-2020)
7.6.2 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by Product Type (2021-2029)
7.7 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) by End User
7.7.1 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2013-2020)
7.7.2 MEA Next Generation Cancer Diagnostic Market Value (US$ Mn) and Volume (Units) Comparison by End User (2021-2029)
7.8 MEA Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate Comparison (2014-2029)
7.8.1 MEA Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by Region
7.8.2 MEA Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by Product Type
7.8.3 MEA Next Generation Cancer Diagnostic Market Y-o-Y Growth Rate by End User
7.9 MEA Next Generation Cancer Diagnostic Market Share Comparison (2013-2029)
7.9.1 MEA Next Generation Cancer Diagnostic Market Share by Region
7.9.2 MEA Next Generation Cancer Diagnostic Market Share by Product Type
7.9.3 MEA Next Generation Cancer Diagnostic Market Share by End User

Chapter 8 Global Next Generation Cancer Diagnostic Market Company Profiles

8.1 Market Competition Scenario Analysis, By Company
8.2 Competitor Landscape
8.3 Company Share Analysis
8.4 Company Profiles
8.4.1 Company
8.4.1.1 Company Overview
8.4.1.2 Business Description
8.4.1.3 Product Portfolio
8.4.1.4 Key Financials
8.4.1.5 Key Developments
8.4.1.6 SWOT Analysis

Companies Included:
GE Healthcare (United States)
Koninklijke Philips N.V. (Netherlands)
F. Hoffmann-La Roche Ltd (Switzerland)
Qiagen (Germany)
Novartis AG (Switzerland)
Abbott (United States)
Thermo Fisher Scientific, Inc. (United States)
Opko Health, Inc. (United States)
Myriad Genetics, Inc (United States)
Agilent Technologies (United States)
Cepheid
PerkinElmer
Genomic Health, Inc.
Illumina, Inc.

Chapter 9 Methodology and Data Source

9.1 Research Approach/ Methodology
9.2 Market Size Estimation
9.3 Market Breakdown and Data Triangulation
9.4 Data Source
9.4.1 Secondary Sources
9.4.2 Primary Sources

Licensing Options

One User
$3900
Enterprise User
$7800